Nanomedicine Research

Our research group is working on developing neuroprotective gene therapy in the form of eye drops that can be administered topically for the retina and optic nerve for patients with glaucoma. The novel eyedrops contain nanoparticles that can be targeted to the back of the eye.

This week we are holding awareness sessions with poster displays of our research in the School of Pharmacy.

Organized by

Foldvari Research Group

Contact: Dr Marianna Foldvari
Contact Email:

Category: Awareness


09/03/2015 - 15/03/2015
All Day


University of Waterloo
School of Pharmacy
N2G 1C5
Loading Map....

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.